World-class patent: Hokkaido Cancer Center's CARNA MED cultivates 7 types of immune cells at the same time
Did you know? Check out Raw Medical Viewpoints and you'll know more!
At the end of the month, the U.S. Department of Health and Human Services (HHS) announced that it has launched a new healthcare system called "Healthy Travel", which will allow users to take advantage of the new healthcare system by using the latest technology, such as the U.S. Department of Health and Human Services (DHHS), and the U.S. Department of Health and Human Services (HHS).
Immuno-cell therapy is an advanced medical technology that utilizes the body's own immune cells to fight cancer and viral infections. In 1985, the National Institutes of Health (NIH) ranked immunotherapy as the fourth most common form of cancer treatment, in addition to surgery, chemotherapy, and radiation therapy.
New immune cell therapy for complete cancer cell elimination
Traditional surgical treatments target localized solid tumors that can be seen with the naked eye, and if the tumor is too complex to remove or if the tumor is a liquid cancer such as a hematological cancer, surgical resection may not be possible. Even after surgery, chemotherapy and radiotherapy are still needed to further remove the invisible cancer cells. However, radiation therapy can only be used to treat solid tumors that are localized and visible to the naked eye, while liquid cancers such as blood cancers that are invisible to the naked eye or blood cancers require chemotherapy to further remove the cancer cells.
However, chemotherapeutic drugs lack specificity and attack normal cells while eliminating cancer cells, which not only reduces the immune system of the patient, but also may cause serious side effects. Prolonged use of chemotherapy drugs may lead to resistance of the cancer cells to the extent that it affects the outcome of many patients with recurrent cancer.
Immunocellular therapy is less likely to cause serious side effects and can target specific cancer cells.
CARNA MED is a global expert in immune cell therapy, with world-class patents, the ability to culture seven types of immune cells at the same time, and a flow cytometer that accurately analyzes cultured cells at tens of thousands of molecules per second, and uses a safe and effective cell culture technique for cellular phenotyping.
CARNA MED World Patent
1) All you need is a blood draw and an IV.
2) Travel to Japan for blood draw and return to Japan for immunocell drip.
3) CARNA MED is the only one in the world that has a patent for culturing 7 types of immune cells at the same time.
-Initial T-cell culture: initial T-cells, helper T-cells, killer T-cells, γδ T-cells, NK cells
-NKNKT cell culture: NK cells, NKT cells, γδ T-cells, helper T-cells, killer T-cells
-DC cell culture: dendritic cells
4) Our flow cytometer can accurately analyze cultured cells at tens of thousands of molecules per second, and we use safe and effective cell culture techniques to perform cell phenotyping.
In 2010, Dendreon's prostate cancer vaccine, Provenge, was approved by the U.S. Food and Drug Administration (FDA), and was included in Medicare the following year. In the same year, Canadian immunologist Steinman was awarded the Nobel Prize in Biomedicine for his discovery that dendritic cells can induce an acquired immune response. It can be seen that immune cell therapy is not only a mature medical technology in the international arena, but also a new trend in the future treatment of cancer. Currently, immune cell therapy in the international application of natural killer cell therapy, T-cell therapy, dendritic cell therapy, autoimmune disease therapy as the main development projects.
The stresses of daily life can lead to dysregulation of the autonomic nervous system, resulting in decreased immunity. After the age of 20, immunity decreases with age.
When the immune function is low, the body will send out the following warning signals:
1. Easily fatigued and tired 2. Easily broken mouth and stomatitis 3. Skin is drier than before
The principle of immune cell therapy: the activated immune cells will be guided back to the body, to achieve the effect of improving the immune system. As we age, our immune system will gradually decline, so as long as we can effectively activate our immune system, we can have a healthier and better life. Immunity boosting also helps the body to fight off bacteria and viruses that invade the body, as well as foreign substances such as cancer cells. When cancer strikes, immune cell culture therapy is highly effective in killing and preventing various complications.
Time Magazine's 100 Most Famous People - Yoshinori Takayanagi, President
Born in Hokkaido, Japan
Motto: Continuous change!
Only through the pursuit of continuous breakthroughs and changes in life can we achieve great things for the happiness of all mankind!
CARNA MED Milestones
1989 - Dr. Yoshinori Takayanagi opens the first eye hospital in Japan, specializing in cataract surgery, with more than 13,700 treatments to date.
2001 - Yoshinori Takayanagi's father passed away from lung cancer, and in order to address the pain caused by cancer, he devoted himself to research in cancer medicine and established the Cancer Comprehensive Medical Center in 2008.
2012 - In order to improve the overall medical technology, Dr. Takayanagi established the CARNA MED Cancer Center in Sapporo, which provides treatment modalities based on genetic diagnosis and immunocellular therapy, as well as a laboratory to study the clinical side effects of anticancer medications and human genetic profiling.
2014 - Time Magazine voted Dr. Takayanagi as one of Asia's top 100 entrepreneurs, and recognized Dr. Takayanagi's medical achievements in a special article.
Topics: Immune Cells, Japan, Biomedical News, Cancer, Cancer Treatment